Cell surface glycosaminoglycans exacerbate plasma membrane perturbation induced by the islet amyloid polypeptide.
amyloid
glycosaminoglycans
islet amyloid polypeptide
membrane perturbation
self-assembly
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
05
08
2020
revised:
14
11
2020
accepted:
09
12
2020
entrez:
21
1
2021
pubmed:
22
1
2021
medline:
16
7
2021
Statut:
ppublish
Résumé
Glycosaminoglycans (GAGs) are long and unbranched anionic heteropolysaccharides that have been associated with virtually all amyloid deposits. Soluble sulfated GAGs are known for their propensity to promote the self-assembly of numerous amyloidogenic proteins and to modulate their cytotoxicity. Nonetheless, although GAGs are prevalent on the outer leaflet of eukaryotic cell plasma membrane as part of proteoglycans, their contributions in the perturbation of lipid bilayer induced by amyloid polypeptides remain unknown. Herein, we investigate the roles of GAGs in the cytotoxicity and plasma membrane perturbation induced by the islet amyloid polypeptide (IAPP), whose deposition in the pancreatic islets is associated with type II diabetes. Cellular assays using GAG-deficient cells reveal that GAGs exacerbate IAPP-induced cytotoxicity and permeabilization of the plasma membrane. Confocal microscopy and flow cytometry analyses show that IAPP sequestration at the cell surface is dependent of GAGs and of the aggregation propensity of the peptide. Using giant plasma membrane vesicles (GPMVs) prepared from GAG-deficient cells, we investigate the direct contributions of membrane-embedded proteoglycans in IAPP-induced membrane disassembly. In sharp contrast to soluble sulfated GAGs, kinetics of amyloid self-assembly expose that the presence of GAGs on GPMVs does not significantly modulate in vitro amyloid formation. Overall, this study indicates that cell surface GAGs increase the local concentration of IAPP in the vicinity of the plasma membrane, promoting lipid bilayer perturbation and cell death.
Identifiants
pubmed: 33475205
doi: 10.1096/fj.202001845R
doi:
Substances chimiques
Amyloid
0
Glycosaminoglycans
0
Islet Amyloid Polypeptide
0
Lipid Bilayers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e21306Informations de copyright
© 2021 Federation of American Societies for Experimental Biology.
Références
Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27-68.
Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA. 1987;84:8628-8632.
Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA. 1987;84:3881-3885.
Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91:795-826.
Luca S, Yau WM, Leapman R, Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry. 2007;46:13505-13522.
Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994;368:756-760.
Jurgens CA, Toukatly MN, Fligner CL, et al. β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol. 2011;178:2632-2640.
Krotee P, Rodriguez JA, Sawaya MR, et al. Atomic structures of fibrillar segments of hIAPP suggest tightly mated beta-sheets are important for cytotoxicity. eLife. 2017;6.1-26.
Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev. 2008;29:303-316.
Jeong HR, An SSA. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus. Clin Interv Aging. 2015;10:1873-1879.
Abedini A, Plesner A, Cao P, et al. Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics. eLife. 2016;5.1-28.
Kisilevsky R. The relation of proteoglycans, serum amyloid P and Apo E to amyloidosis current status, 2000. Amyloid. 2000;7:23-25.
Gellermann GP, Appel TR, Tannert A, et al. Raft lipids as common components of human extracellular amyloid fibrils. Proc Natl Acad Sci USA. 2005;102:6297-6302.
Ancsin JB. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid. 2003;10:67-79.
Madine J. Cofactor-mediated amyloidogenesis. Biosci Rep. 2019;39(3).
Nguyen PT, Andraka N, De Carufel CA, Bourgault S. Mechanistic contributions of biological cofactors in islet amyloid polypeptide amyloidogenesis. J Diab Res. 2015;2015:515307.
Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4-27.
Young ID, Ailles L, Narindrasorasak S, Tan R, Kisilevsky R. Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus. Arch Pathol Lab Med. 1992;116:951-954.
Papy-Garcia D, Christophe M, Huynh MB, et al. Glycosaminoglycans, protein aggregation and neurodegeneration. Curr Protein Pept Sci. 2011;12:258-268.
Castillo GM, Cummings JA, Yang W, et al. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes. 1998;47:612-620.
De Carufel CA, Nguyen PT, Sahnouni S, Bourgault S. New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicity. Pept Sci. 2013;100:645-655.
Jha S, Patil SM, Gibson J, Nelson CE, Alder NN, Alexandrescu AT. Mechanism of amylin fibrillization enhancement by heparin. J Biol Chem. 2011;286:22894-22904.
Wang H, Cao P, Raleigh DP. Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions. J Mol Biol. 2013;425:492-505.
Quittot N, Sebastiao M, Bourgault S. Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance. Biochem Cell Biol = Biochimie et biologie cellulaire. 2017;95:329-337.
Bourgault S, Solomon JP, Reixach N, Kelly JW. Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion. Biochemistry. 2011;50:1001-1015.
McLaurin J, Franklin T, Zhang X, Deng J, Fraser PE. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur J Biochem. 1999;266:1101-1110.
Relini A, De Stefano S, Torrassa S, et al. Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem. 2008;283:4912-4920.
Solomon JP, Bourgault S, Powers ET, Kelly JW. Heparin binds 8 kDa gelsolin cross-beta-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension. Biochemistry. 2011;50:2486-2498.
Sebastiao M, Quittot N, Marcotte I, Bourgault S. Glycosaminoglycans induce amyloid self-assembly of a peptide hormone by concerted secondary and quaternary conformational transitions. Biochemistry. 2019;58:1214-1225.
Bergamaschini L, Donarini C, Rossi E, De Luigi A, Vergani C, Grazia De Simoni M. Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro. Neurobiol Aging. 2002;23:531-536.
Madine J, Middleton DA. Comparison of aggregation enhancement and inhibition as strategies for reducing the cytotoxicity of the aortic amyloid polypeptide medin. Euro Biophys J: EBJ. 2010;39:1281-1288.
Maiza A, Chantepie S, Vera C, et al. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration. FEBS Lett. 2018;592:3806-3818.
Oskarsson ME, Singh K, Wang J, Vlodavsky I, Li J-P, Westermark GT. Heparan sulfate proteoglycans are important for islet amyloid formation and islet amyloid polypeptide-induced apoptosis. J Biol Chem. 2015;290:15121-15132.
Potter KJ, Werner I, Denroche HC, et al. Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase. Am J Transplant. 2015;15:1519-1530.
Templin AT, Mellati M, Soininen R, et al. Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice. Protein Eng, Design Sel: PEDS. 2019;32:95-102.
Abedini A, Schmidt AM. Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett. 2013;587:1119-1127.
Raleigh D, Zhang X, Hastoy B, Clark A. The beta-cell assassin: IAPP cytotoxicity. J Mol Endocrinol. 2017;59:R121-R140.
Brender JR, Salamekh S, Ramamoorthy A. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc Chem Res. 2012;45:454-462.
Caillon L, Hoffmann ARF, Botz A, Khemtemourian L. Molecular Structure, membrane interactions, and toxicity of the islet amyloid polypeptide in type 2 diabetes mellitus. J Diab Res. 2016;2016:5639875.
Engel MFM. Membrane permeabilization by Islet Amyloid Polypeptide. Chem Phys Lipid. 2009;160:1-10.
Engel MFM, Khemtémourian L, Kleijer CC, et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc Natl Acad Sci USA. 2008;105:6033-6038.
Green JD, Kreplak L, Goldsbury C, et al. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. J Mol Biol. 2004;342:877-887.
Mirzabekov TA, Lin M-C, Kagan BL. Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem. 1996;271:1988-1992.
Godin E, Nguyen PT, Zottig X, Bourgault S. Identification of a hinge residue controlling islet amyloid polypeptide self-assembly and cytotoxicity. J Biol Chem. 2019;294:8452-8463.
Abedini A, Raleigh DP. Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide. Org Lett. 2005;7:693-696.
Esko JD, Stewart TE, Taylor WH. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci. 1985;82:3197-3201.
Quittot N, Sebastiao M, Al-Halifa S, Bourgault S. Kinetic and conformational insights into islet amyloid polypeptide self-assembly using a biarsenical fluorogenic probe. Bioconjug Chem. 2018;29:517-527.
Sandwall E, O'Callaghan P, Zhang X, Lindahl U, Lannfelt L, Li J-P. Heparan sulfate mediates amyloid-beta internalization and cytotoxicity. Glycobiology. 2010;20:533-541.
Bejoy J, Song L, Wang Z, Sang QX, Zhou Y, Li Y. Neuroprotective activities of heparin, heparinase III, and hyaluronic acid on the abeta42-Treated forebrain spheroids derived from human stem cells. ACS Biomater Sci Eng. 2018;4:2922-2933.
Bradshaw AC, Parker AL, Duffy MR, et al. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. PLoS Pathog. 2010;6:e1001142.
Sezgin E, Kaiser HJ, Baumgart T, Schwille P, Simons K, Levental I. Elucidating membrane structure and protein behavior using giant plasma membrane vesicles. Nat Protoc. 2012;7:1042-1051.
Carles J. Colorimetric microdetermination of phosphorus. Bulletin de la Societe de chimie biologique. 1956;38:255-257.
Birol M, Kumar S, Rhoades E, Miranker AD. Conformational switching within dynamic oligomers underpins toxic gain-of-function by diabetes-associated amyloid. Nat Commun. 2018;9:1312.
Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem. 2005;280:17294-17300.
Kayed R, Head E, Thompson JL, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486-489.
LeVine H 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993;2:404-410.
Sebastiao M, Quittot N, Bourgault S. Thioflavin T fluorescence to analyse amyloid formation kinetics: measurement frequency as a factor explaining irreproducibility. Anal Biochem. 2017;532:83-86.
Hawe A, Sutter M, Jiskoot W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res. 2008;25:1487-1499.
Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA. 1990;87:5036-5040.
Magzoub M, Miranker AD. Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J. 2012;26:1228-1238.
De Carufel CA, Quittot N, Nguyen PT, Bourgault S. Delineating the role of helical intermediates in natively unfolded polypeptide amyloid assembly and cytotoxicity. Angew Chem Int Ed. 2015127(48):14591-14595.
Schlamadinger DE, Miranker AD. Fiber-dependent and -independent toxicity of islet amyloid polypeptide. Biophys J. 2014;107:2559-2566.
Hong Y, Meng L, Chen S, et al. Monitoring and inhibition of insulin fibrillation by a small organic fluorogen with aggregation-induced emission characteristics. J Am Chem Soc. 2012;134:1680-1689.
Vidal J, Verchere CB, Andrikopoulos S, et al. The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice. Diabetologia. 2003;46:71-79.
Pepys MB, Rademacher TW, Amatayakul-Chantler S, et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA. 1994;91:5602-5606.
Last NB, Schlamadinger DE, Miranker AD. A common landscape for membrane-active peptides. Protein Sci. 2013;22:870-882.
Gurlo T, Ryazantsev S, Huang C-J, et al. Evidence for proteotoxicity in β cells in type 2 diabetes : toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol. 2010;176:861-869.
Raleigh D, Zhang X, Hastoy B, Clark A. The β-cell assassin: IAPP cytotoxicity. J Mol Endocrinol. 2017;59:R121-R140.
Huang CJ, Lin CY, Haataja L, et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes. 2007;56:2016-2027.
Kim J, Cheon H, Jeong YT, et al. Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes. J Clin Investig. 2014;124:3311-3324.
Shigihara N, Fukunaka A, Hara A, et al. Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy. J Clin Investig. 2014;124:3634-3644.
Rivera JF, Gurlo T, Daval M, et al. Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death Differ. 2011;18:415-426.
Hull RL, Zraika S, Udayasankar J, Aston-Mourney K, Subramanian SL, Kahn SE. Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress. Diabetologia. 2009;52:1102-1111.
Aston-Mourney K, Hull RL, Zraika S, Udayasankar J, Subramanian SL, Kahn SE. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets. Diabetologia. 2011;54:1756-1765.
Park YJ, Lee S, Kieffer TJ, et al. Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide. Diabetologia. 2012;55(4):1035-1047.
Abedini A, Cao P, Plesner A, et al. RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity. J Clin Investig. 2018;128:682-698.
Holmes BB, DeVos SL, Kfoury N, et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci USA. 2013;110:E3138-E3147.
Ihse E, Yamakado H, van Wijk XM, Lawrence R, Esko JD, Masliah E. Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type. Sci Rep. 2017;7:9008.
Wesen E, Gallud A, Paul A, Lindberg DJ, Malmberg P, Esbjorner EK. Cell surface proteoglycan-mediated uptake and accumulation of the Alzheimer's disease peptide Abeta(1-42). Biochim Biophys Acta. 2018;1860:2204-2214.
Trikha S, Jeremic AM. Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells. PLoS ONE. 2013;8:e73080.
Mukherjee A, Morales-Scheihing D, Salvadores N, et al. Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism. J Exp Med. 2017;214:2591-2610.